Download FREE Report Sample
Download Free sampleNeuromyelitis optica spectrum disorder (NMOSD), also known as Devic disease, is a chronic disorder of the brain and spinal cord dominated by inflammation of the optic nerve (optic neuritis) and the spinal cord (myelitis). Classically, it was felt to be a monophasic illness, consisting of episodes of inflammation of one or both optic nerves and the spinal cord over a short period of time (days or weeks) but, after the initial episode, no recurrence. It is now recognized that most patients satisfying current criteria for NMOSD experience repeated attacks separated by periods of remission. The interval between attacks may be weeks, months or years.
Neuromyelitis Optica Spectrum Disorder Market contains market size and forecasts of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Global, including the following market information:
The global Neuromyelitis Optica Spectrum Disorder (NMOSD) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravenous Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuromyelitis Optica Spectrum Disorder (NMOSD) include F. Hoffmann-La Roche Ltd, Alexion Pharmaceuticals, RemeGen, Nihon Pharmaceutical, Harbour BioMed, Lundbeck, Bionure, Opexa Therapeutics and TG Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Neuromyelitis Optica Spectrum Disorder (NMOSD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Segment Percentages, by Type, 2021 (%)
Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Segment Percentages, by Application, 2021 (%)
Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
